Skip to main content

Gilgamesh Pharmaceuticals

New York, United States

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

$60.0M raised
Mar 2026
Series A

Top Investors

Alumni VenturesGaingelsY CombinatorPioneer FundBossa Invest

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gilgamesh Pharmaceuticals

How much funding has Gilgamesh Pharmaceuticals raised?
Gilgamesh Pharmaceuticals has raised $60.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
Who are Gilgamesh Pharmaceuticals's investors?
Gilgamesh Pharmaceuticals's investors include Alumni Ventures, Gaingels, Y Combinator, Pioneer Fund, Bossa Invest.
Where is Gilgamesh Pharmaceuticals headquartered?
Gilgamesh Pharmaceuticals is headquartered in New York, United States.
What does Gilgamesh Pharmaceuticals do?
Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.
What stage is Gilgamesh Pharmaceuticals at?
Gilgamesh Pharmaceuticals is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Gilgamesh Pharmaceuticals — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/gilgamesh-pharmaceuticals. Accessed July 1, 2026.
APA
VCBacked. (2026). Gilgamesh Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/gilgamesh-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Gilgamesh Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/gilgamesh-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .